Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
Background/AimsPortal-vein thrombosis (PVT) develops in 10-25% of cirrhotic patients and may aggravate portal hypertension. There are few data regarding the effects of anticoagulation on nonmalignant PVT in liver cirrhosis. The aim of this study was to elucidate the safety, efficacy, and predictors...
Main Authors: | Jung Wha Chung, Gi Hyun Kim, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2014-12-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-20-384.pdf |
Similar Items
-
Management of Nonmalignant Portal Vein Thrombosis in Cirrhosis
by: Francisco Capinha, et al.
Published: (2023-10-01) -
The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study
by: Zhiji Chen, et al.
Published: (2021-06-01) -
Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
by: Ho Soo Chun, et al.
Published: (2021-10-01) -
The Effect of Anticoagulant in Patients with Cirrhosis Associated with Acute Portal Vein Thrombosis
by: Hoon Gil Jo, et al.
Published: (2021-09-01) -
Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients
by: Irina Girleanu, et al.
Published: (2014-01-01)